Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years.

Hu, Mao; Wong, Hui Lee; Feng, Yuhui; Lloyd, Patricia C; Smith, Elizabeth R; Amend, Kandace L; Kline, Annemarie; Beachler, Daniel C; Gruber, Joann F; Mitra, Mahasweta; Seeger, John D; Harris, Charlalynn; Secora, Alex; Obidi, Joyce; Wang, Jing; Song, Jennifer; McMahill-Walraven, Cheryl N; Reich, Christian; McEvoy, Rowan; Do, Rose; Chillarige, Yoganand; Clifford, Robin; Cooper, Danielle D; Shoaibi, Azadeh; Forshee, Richard; Anderson, Steven A

Hu, Mao; Wong, Hui Lee; Feng, Yuhui; Lloyd, Patricia C; Smith, Elizabeth R; Amend, Kandace L; Kline, Annemarie; Beachler, Daniel C; Gruber, Joann F; Mitra, Mahasweta; Seeger, John D; Harris, Charlalynn; Secora, Alex; Obidi, Joyce; Wang, Jing; Song, Jennifer; McMahill-Walraven, Cheryl N; Reich, Christian; McEvoy, Rowan; Do, Rose; Chillarige, Yoganand; Clifford, Robin; Cooper, Danielle D; Shoaibi, Azadeh; Forshee, Richard; Anderson, Steven A.

Afiliação

Hu M; Acumen, Burlingame, California.
Wong HL; US Food and Drug Administration, Silver Spring, Maryland.
Feng Y; Acumen, Burlingame, California.
Lloyd PC; US Food and Drug Administration, Silver Spring, Maryland.
Smith ER; Acumen, Burlingame, California.
Amend KL; Optum Epidemiology, Boston, Massachusetts.
Kline A; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania.
Beachler DC; HealthCore, Wilmington, Delaware.
Gruber JF; US Food and Drug Administration, Silver Spring, Maryland.
Mitra M; Acumen, Burlingame, California.
Seeger JD; Optum Epidemiology, Boston, Massachusetts.
Harris C; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania.
Secora A; IQVIA, Falls Church, Virginia.
Obidi J; US Food and Drug Administration, Silver Spring, Maryland.
Wang J; Acumen, Burlingame, California.
Song J; Optum Epidemiology, Boston, Massachusetts.
McMahill-Walraven CN; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania.
Reich C; IQVIA, Falls Church, Virginia.
McEvoy R; Acumen, Burlingame, California.
Do R; Acumen, Burlingame, California.
Chillarige Y; Acumen, Burlingame, California.
Clifford R; Optum Epidemiology, Boston, Massachusetts.
Cooper DD; CVS Health Clinical Trial Services, Blue Bell, Pennsylvania.
Shoaibi A; US Food and Drug Administration, Silver Spring, Maryland.
Forshee R; US Food and Drug Administration, Silver Spring, Maryland.
Anderson SA; US Food and Drug Administration, Silver Spring, Maryland.

JAMA Pediatr ; 177(7): 710-717, 2023 07 01.

Article em En | MEDLINE | ID: mdl-37213095

Assuntos

Vacinas contra COVID-19; COVID-19; Miocardite; Pericardite; Criança; Feminino; Humanos; Masculino; Vacina BNT162; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacinas contra COVID-19/administração & dosagem; Vacinas contra COVID-19/efeitos adversos; Estados Unidos/epidemiologia; Vacinação/efeitos adversos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 2_muertes_prevenibles / 4_covid_19 / 4_pneumonia / 6_cardiovascular_diseases / 6_other_circulatory_diseases / 6_other_respiratory_diseases / 7_infections / 7_non_communicable_diseases Assunto principal: Pericardite / Vacinas contra COVID-19 / COVID-19 / Miocardite Tipo de estudo: Prognostic_studies / Screening_studies Limite: Child / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: JAMA Pediatr Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google